Caseware UK (AP4) 2023.0.135 2023.0.135 2024-11-302024-11-3012true2023-12-01falseThat of a holding companytrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 13721477 2023-12-01 2024-11-30 13721477 2023-01-01 2023-11-30 13721477 2024-11-30 13721477 2023-11-30 13721477 c:Director1 2023-12-01 2024-11-30 13721477 d:CurrentFinancialInstruments 2024-11-30 13721477 d:CurrentFinancialInstruments 2023-11-30 13721477 d:Non-currentFinancialInstruments 2024-11-30 13721477 d:Non-currentFinancialInstruments 2023-11-30 13721477 d:CurrentFinancialInstruments d:WithinOneYear 2024-11-30 13721477 d:CurrentFinancialInstruments d:WithinOneYear 2023-11-30 13721477 d:Non-currentFinancialInstruments d:AfterOneYear 2024-11-30 13721477 d:Non-currentFinancialInstruments d:AfterOneYear 2023-11-30 13721477 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-11-30 13721477 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-11-30 13721477 d:ShareCapital 2024-11-30 13721477 d:ShareCapital 2023-11-30 13721477 d:RetainedEarningsAccumulatedLosses 2024-11-30 13721477 d:RetainedEarningsAccumulatedLosses 2023-11-30 13721477 c:FRS102 2023-12-01 2024-11-30 13721477 c:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 13721477 c:FullAccounts 2023-12-01 2024-11-30 13721477 c:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 13721477 6 2023-12-01 2024-11-30 13721477 e:PoundSterling 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Registered number: 13721477










MEREOLOGY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2024

 
MEREOLOGY LIMITED
REGISTERED NUMBER: 13721477

BALANCE SHEET
AS AT 30 NOVEMBER 2024

2024
As restated
2023
Note
£
£

Fixed assets
  

Investments
 4 
1
1

  
1
1

Current assets
  

Debtors: amounts falling due within one year
 5 
392,857
-

Cash at bank and in hand
 6 
955
-

  
393,812
-

Creditors: amounts falling due within one year
 7 
(143,857)
-

Net current assets
  
 
 
249,955
 
 
-

Total assets less current liabilities
  
249,956
1

Creditors: amounts falling due after more than one year
  
(250,000)
-

  

Net (liabilities)/assets
  
(44)
1


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
(45)
-

  
(44)
1


Page 1

 
MEREOLOGY LIMITED
REGISTERED NUMBER: 13721477
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Dr P Rivers
Director

Date: 8 April 2025

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
MEREOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

1.


General information

The entity is a private company limited by shares, incorporated in England and Wales, registration number 13721477. The registered office is Unit 2, Meridian South, Leicester, LE19 1WY.
Principal activity
The principal activity of the Company was that of a holding company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The Company's functional and presentational currency is British Pound Sterling (£).
The principal accounting policies adopted in the preparation of the financial statements are set out below.

 
2.2

Exemption from preparing consolidated financial statements

The Company, and the Group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and Group are considered eligible for the exemption to prepare consolidated accounts.

 
2.3

Finance costs

Finance costs are charged to the Statement of Comprehensive Income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.4

Borrowing costs

All borrowing costs are recognised in the Statement of Comprehensive Income in the year in which they are incurred.

 
2.5

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
MEREOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

2.Accounting policies (continued)

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at transaction price, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2023 - 1).


4.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 December 2023
1



At 30 November 2024
1





5.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
392,857
-

392,857
-


Page 4

 
MEREOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
955
-

955
-



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
142,857
-

Amounts owed to group undertakings
1,000
-

143,857
-


Maven MEIF (EM) GP (One) Limited hold a fixed and floating charge of all property and undertakings of the Company.


8.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
250,000
-

250,000
-


Maven MEIF (EM) GP (One) Limited hold a fixed and floating charge of all property and undertakings of the Company.

Page 5

 
MEREOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

9.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£

Amounts falling due within one year

Bank loans
142,857
-


142,857
-


Amounts falling due 2-5 years

Bank loans
250,000
-


250,000
-


392,857
-



10.


Prior year adjustment

These financial statements include a restatement to the comparative Balance Sheet for the year ended 30/11/2023.
The restatement relates to the recognition of the investment in a subsidiary. The subsidiary was acquired on 30/11/2023 for £1. The resulting adjustment reduced cash at bank and in hand by £1 and increased fixed asset investments by £1. 


11.


Related party transactions

In accordance with FRS 102 35.1AC, the Company is exempt from requirements to disclose transactions with other wholly owned members of the group.
All transactions are considered to be at arms length.


12.


Controlling party

The ultimate controlling party is Dr Paul Edmund Rivers.

 
Page 6